Machine Learning to Predict Teratogenicity: Theory and Practice

Area of Science:

• Computational toxicology
• Artificial intelligence in drug development

Background:

• Machine learning (ML) is advancing rapidly, driving significant progress in artificial intelligence (AI).
• There is a growing need to apply ML techniques to the field of teratogenicity assessment.
• Experimental studies for teratogenicity face limitations that ML can help overcome.

Purpose of the Study:

• To describe the application of ML in investigating teratogenicity.
• To highlight ML's potential in assessing developmental toxicity of agents and medicinal products.

Main Methods:

• Utilizing ML algorithms for pattern recognition and data analysis.
• Employing ML for tasks including classification, regression, clustering, and anomaly detection.
• Developing ML-based decision systems for teratogenicity assessment.

Main Results:

• ML provides robust methods to analyze complex datasets related to teratogenicity.
• ML can effectively classify agents as teratogenic or non-teratogenic.
• ML aids in determining the teratogenic potential of substances.

Conclusions:

• ML offers a powerful, data-driven approach to investigate teratogenicity.
• ML can enhance the assessment of drug safety and inform decisions on medicinal product use.
• ML-based methods can overcome limitations inherent in traditional experimental teratogenicity studies.